User profiles for Bruce Kirenga
Bruce KirengaChief Research Scientist and Director Makerere University Lung Institute Verified email at chs.mak.ac.ug Cited by 1464 |
Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low-and middle-income country settings
Rationale: Forty percent of households worldwide burn biomass fuels for energy, which may
be the most important contributor to household air pollution. Objectives: To examine the …
be the most important contributor to household air pollution. Objectives: To examine the …
[HTML][HTML] The health and social implications of household air pollution and respiratory diseases
…, C Roa, ME Crocker, GE Gianella, BJ Kirenga… - NPJ primary care …, 2019 - nature.com
Approximately three billion individuals are exposed to household air pollution (HAP) from
the burning of biomass fuels worldwide. Household air pollution is responsible for 2.9 million …
the burning of biomass fuels worldwide. Household air pollution is responsible for 2.9 million …
[HTML][HTML] International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review
…, A Wanner, M Edwards, AD Harries, BJ Kirenga… - BMJ global …, 2018 - gh.bmj.com
Introduction Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory
disease due to residual lung damage. Yet, the WHO End TB strategy does not mention post-TB …
disease due to residual lung damage. Yet, the WHO End TB strategy does not mention post-TB …
[HTML][HTML] Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey
BJ Kirenga, C de Jong, W Katagira, S Kasozi… - BMC public health, 2019 - Springer
Background Recent large-scale population data on the prevalence of asthma and its risk
factors are lacking in Uganda. This survey was conducted to address this data gap. Methods A …
factors are lacking in Uganda. This survey was conducted to address this data gap. Methods A …
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
…, N Ilina, JC Ivancevich, G Joos, M Khaitov, B Kirenga… - Allergy, 2021 - Wiley Online Library
To the Editor, A novel strain of human coronaviruses, the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), named by the International Committee on Taxonomy of …
coronavirus 2 (SARS-CoV-2), named by the International Committee on Taxonomy of …
[HTML][HTML] Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing
Background Understanding the emergence and spread of multidrug-resistant tuberculosis (MDR-TB)
is crucial for its control. MDR-TB in previously treated patients is generally …
is crucial for its control. MDR-TB in previously treated patients is generally …
National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned
…, L Kendall, H Kipruto, BJ Kirenga… - Tropical Medicine & …, 2020 - Wiley Online Library
Objective and methods Worldwide, tuberculosis (TB) is the leading cause of death from a
single infectious agent. In many countries, national TB prevalence surveys are the only way to …
single infectious agent. In many countries, national TB prevalence surveys are the only way to …
[HTML][HTML] Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis
…, B Brown, P Manga, B Kirenga… - … England Journal of …, 2014 - Mass Medical Soc
Background Tuberculous pericarditis is associated with high morbidity and mortality even if
antituberculosis therapy is administered. We evaluated the effects of adjunctive …
antituberculosis therapy is administered. We evaluated the effects of adjunctive …
[HTML][HTML] Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional …
F van Gemert, B Kirenga, N Chavannes… - The Lancet Global …, 2015 - thelancet.com
Background In sub-Saharan Africa, little is known about the damage to respiratory health
caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic …
caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic …
[HTML][HTML] Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised …
…, CY Chiang, F Conradie, M Gurumurthy, B Kirenga… - The Lancet, 2022 - thelancet.com
Background The STREAM stage 1 trial showed that a 9-month regimen for the treatment of
rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011 WHO-recommended …
rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011 WHO-recommended …